Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Inhalation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

Cyclophosphamide 767 Carboplatin 667 Paclitaxel 621 Bevacizumab 612 pembrolizumab 586 Cisplatin 575 Gemcitabine 520 Docetaxel 490 Radiotherapy 471 Rituximab 471 Dexamethasone 423 Nivolumab 396 Doxorubicin 378 Capecitabine 337 Fluorouracil 328 Etoposide 304 Oxaliplatin 283 Pemetrexed 282 Cytarabine 281 Lenalidomide 275 Prednisone 272 fludarabine phosphate 266 Erlotinib Hydrochloride 263 Leucovorin 255 fludarabine 254 Trastuzumab 249 Bortezomib 240 Vincristine 239 Filgrastim 238 Cetuximab 227

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04481035 2025-07-31

NF1NAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed

5 enrolled 10 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡